Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Investigation into the Release of Respiratory Aerosols by Brass Instruments and Mitigation Measures with Respect to Covid-19

View ORCID ProfileAlexander S. Parker, Kenneth Crookston
doi: https://doi.org/10.1101/2020.07.31.20165837
Alexander S. Parker
1Brass Bands England, Barnsley, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander S. Parker
  • For correspondence: alexander.s.parker@gmail.com
Kenneth Crookston
1Brass Bands England, Barnsley, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

There are a number of recent studies detailing the transmission of SARS-CoV-2 (Covid-19) via both Droplet and Aerosol airborne particle routes of infection. Because of this, it is necessary to understand the release of different sized particles in activities such as playing brass instruments in order for an analysis of risk to take place for such activities.

In this investigation, the quantity and size of particles released by brass instruments while they are played was analysed for 7 different types of brass instrument. This was contrasted with the same individuals breathing as a comparison for more general activities as well as the effect of a mitigating polycotton barrier over the end of their instruments. To investigate the particles released, the particles were size sorted and counted with a six-channel laser particle counter. Multiple measurements were made by each individual in each condition investigated. The mean concentration exiting across all instruments measured was found to be 1.21×107 ±1.03×106 Aerosol type particles/m3 and 1.43×104 ±9.01×102 Droplet type particles/m3 per minute. When breathing, the mean count was 1.61×107 ±1.33×106 Aerosol type particle/m3 and 5.45×103 ±1.20×103 Droplet type particles/m3. When playing with a barrier cover, the mean number of particles emitted fell to 2.60×106 ±2.11×105 Aerosol type particle/m3 and 5.20×103 ±8.02×102 Droplet type particles/m3. This barrier represented an average 78.5% reduction for the number of respiratory Aerosol type particles and 63.8% reduction for Droplet type particles compared to playing an instrument without the barrier covering.

It was investigated what effect playing for a more extended period of time had on the release of particles with comparisons made to singing, breathing and covering the instruments’ bell ends with a barrier cap. This showed that the mean number of Aerosol type particles produced while playing was 5.38×107 ±3.15×106 Aerosol type particles/m3 produced and showed a significant drop in Aerosol type particle production when playing with a barrier used, with a mean average of 2.28×106±8.01×104 Aerosol type particles/m3. Both breathing and singing showed consistent numbers of Aerosol type particles produced with means of 6.59×107 ±7.94×105 Aerosol type particles/m3 and 5.28×107 ±5.36×105 Aerosol type particles/m3 respectively. This showed a drop in mean Aerosol type particles/m of 95.7% when using a barrier cap compared to playing without a barrier.

It is concluded that, while playing a brass instrument, the propagation of respiratory Aerosols does occur and, to a smaller extent, so do Droplet size particles, but at a lower level than when the subject was breathing without an instrument. Finally, it was shown that the use of a barrier cap on the bell end of the instrument offers a significant reduction in the production of respiratory Aerosols into the immediate surroundings, which offers a possible mitigation method for playing in groups from the release of Aerosol type particles, especially in hard to ventilate spaces.

Funding This study was supported by funds from Arts Council England covering salary support for AP and KC. The cleanroom facility and particle counter were provisioned by Centre Stage Ltd. The funders did not have a role in the experimental design, data collection, analysis or decision to publish and content of the manuscript.

Competing Interests The authors have declared working for Brass Bands England, which exists to support brass bands in England and the wider UK.

Competing Interest Statement

The authors have declared working for Brass Bands England, which exists to support brass bands in England and the wider UK.

Funding Statement

This study was supported by funds from Arts Council England covering salary support for AP and KC. The cleanroom facility and particle counter were provisioned by Centre Stage Ltd. The funders did not have a role in the experimental design, data collection, analysis or decision to publish and content of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was obtained from Brass Bands England's Board and informed consent was obtained in writing from all participants.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 04, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Investigation into the Release of Respiratory Aerosols by Brass Instruments and Mitigation Measures with Respect to Covid-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Investigation into the Release of Respiratory Aerosols by Brass Instruments and Mitigation Measures with Respect to Covid-19
Alexander S. Parker, Kenneth Crookston
medRxiv 2020.07.31.20165837; doi: https://doi.org/10.1101/2020.07.31.20165837
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Investigation into the Release of Respiratory Aerosols by Brass Instruments and Mitigation Measures with Respect to Covid-19
Alexander S. Parker, Kenneth Crookston
medRxiv 2020.07.31.20165837; doi: https://doi.org/10.1101/2020.07.31.20165837

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (144)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (72)
  • Dermatology (49)
  • Emergency Medicine (147)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (173)
  • Epidemiology (4906)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (689)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (322)
  • Health Systems and Quality Improvement (209)
  • Hematology (86)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5408)
  • Intensive Care and Critical Care Medicine (333)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (128)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (201)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (787)
  • Public and Global Health (1832)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (257)
  • Rheumatology (87)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (38)